Smith & Nephew plc's current cash is $750M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), SNN shows a current cash of $750M. That compares with $680M in the prior-year period — up 11.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SNN's current cash is now $750M (was $680M) — a 11.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Smith & Nephew plc is outperforming or lagging.
Tracking SNN's current cash over time shows whether Smith & Nephew plc is scaling, shrinking, or reshaping that part of the business. The current reading is $750M That compares with $680M in the prior-year period — up 11.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Smith & Nephew plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $750M) with ownership activity and broader fundamentals.
Smith & Nephew plc's current cash is $750M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.